Literature DB >> 8944021

Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.

I Garkavtsev1, A Kazarov, A Gudkov, K Riabowol.   

Abstract

Using a new strategy for tumour suppressor gene isolation based on subtractive hybridization and the subsequent selection of transforming 'genetic suppressor elements', we have cloned a novel gene called ING1 encoding a 33-kD protein (p33ING1) that displays characteristics of a tumour suppressor. Acute expression of transfected constructs encoding this gene inhibited cell growth while chronic expression of ING1 antisense constructs promoted cell transformation. Limited analyses of tumour cell lines show that mutation of the ING1 gene occurs in neuroblastoma cells and reduced expression was seen in some breast cancer cell lines. These results demonstrate that ING1 can act as a potent growth regulator in normal and in established cells and provide evidence for a role as a candidate tumour suppressor gene whose inactivation may contribute to the development of cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944021     DOI: 10.1038/ng1296-415

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  97 in total

1.  UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.

Authors:  M Scott; F M Boisvert; D Vieyra; R N Johnston; D P Bazett-Jones; K Riabowol
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 2.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

3.  Critical determinants for chromatin binding by Saccharomyces cerevisiae Yng1 exist outside of the plant homeodomain finger.

Authors:  Adam Chruscicki; Vicki E Macdonald; Barry P Young; Christopher J R Loewen; Leann J Howe
Journal:  Genetics       Date:  2010-03-29       Impact factor: 4.562

4.  Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Authors:  Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl T Riabowol; Andreas von Deimling
Journal:  J Neurooncol       Date:  2007-09-01       Impact factor: 4.130

5.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Genetic synthetic lethality screen at the single gene level in cultured human cells.

Authors:  A H Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

7.  Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.

Authors:  A Nourani; Y Doyon; R T Utley; S Allard; W S Lane; J Côté
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.

Authors:  G S Nouman; J J Anderson; S Crosier; J Shrimankar; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 9.  The role of the tumour suppressor p33 ING1b in human neoplasia.

Authors:  G S Nouman; J J Anderson; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

10.  Cytoplasmic expression of p33(ING1b) is correlated with tumorigenesis and progression of human esophageal squamous cell carcinoma.

Authors:  Zhen-Long Zhu; Bao-Yong Yan; Yu Zhang; Yan-Hong Yang; Zheng-Min Wang; Hong-Zhen Zhang; Ming-Wei Wang; Xiang-Hong Zhang; Xiao-Feng Sun
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.